These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [A preliminary analysis of unrelated marrow transplantations facilitated by the Japan Marrow Donor Program (JMDP)]. Okamoto S, Harada M, Kato S, Morishima Y, Imamura M, Tsuchiya S, Yamada Y, Kodo H, Hoshi Y, Tsuchida M. Rinsho Ketsueki; 1995 Jun 04; 36(6):524-9. PubMed ID: 7643445 [Abstract] [Full Text] [Related]
8. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G, Vacca A, De Stefano P, Piras E, Ledda A, Piroddi A, Littera R, Nesci S, Locatelli F. Ann N Y Acad Sci; 2005 Jun 04; 1054():186-95. PubMed ID: 16339665 [Abstract] [Full Text] [Related]
10. Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study. Bradley BA, Hows JM, Gore SM, Bidwell JL, Clay T, Downie TR, Gluckman E, Howard MR, Laundy GJ. Clin Transpl; 1992 Jun 04; ():91-107. PubMed ID: 1306726 [Abstract] [Full Text] [Related]
11. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR. Biol Blood Marrow Transplant; 2001 Jun 04; 7(11):620-30. PubMed ID: 11760150 [Abstract] [Full Text] [Related]
12. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors]. Nachbaur D, Schwaighofer H, Thaler J, Weyrer W, Fink M, Nussbaumer W, Fritsch E, Niederwieser D. Wien Klin Wochenschr; 1994 Jun 04; 106(7):201-7. PubMed ID: 8197754 [Abstract] [Full Text] [Related]
20. Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD. Wawer A, Laws HJ, Dilloo D, Göbel U, Burdach S. Klin Padiatr; 2004 Jan 04; 216(3):169-75. PubMed ID: 15175962 [Abstract] [Full Text] [Related] Page: [Next] [New Search]